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Abstract
Introduction: Due to the pandemic of COVID-19 a number of National Health Service (NHS) Trusts in the UK
adopted telephone consultations for patients who were shielding. As the pandemic continues to affect these services an
evaluation was conducted to determine whether telephone consultations implemented during the pandemic should be
maintained long term. The objective was to evaluate this new service and to understand patient experience.
Methods: This study was conducted via a telephone survey. Staff working in the Macmillan centres across the Trust
called patients to survey them about their experience of telephone consultations. Data were collected 23/06/20 – 17/07/
20. A mix of eight open and closed questions were asked. Data were collected on an Excel spreadsheet and patient
identifiable information was anonymised.
Results: 55 patients accepted to participate in this study. Out of 55, 39 patients rated the phone consultation they had
as either 4 or 5 out of 5. When asked if they would like to continue with phone clinics 33 said they would. The majority
of consultations were conducted by doctors (43/55). Patients commented they had received great support from their
healthcare professionals and they felt that phone consultations were safer in the current climate. Three of the patients
felt the calls were rushed and others found it difficult to discuss pain management, sides effects and post-surgery issues.
Conclusions: This evaluation provides a brief snapshot of the experience cancer patients are having with phone clinics.
A re-evaluation will take place once video consultations are implemented.
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Introduction
Healthcare systems across the world had to rapidly
implement innovative changes to continue safe, effec-
tive care of their patients as COVID-19 started to
spread at the beginning of 2020.1 The World Health
Organisation (WHO) declared the COVID-19 virus a
pandemic on 11th March 2020.2 One of the innovative
methods that healthcare systems chose was to intro-
duce virtual care. There are several different terms
used for virtual care. Shaw et al describe it as any
remote interaction between a patient and a healthcare
provider using technology.3 Miah et al named it tele-
medicine4 and Tashkandi et al have coined the appli-
cation of telemedicine in oncology as teleoncology.5
There is plenty of evidence for the benefits of virtual
care which have shown successful application of tech-
nology in palliative care, survivorship care and symp-
tom management.5–8 Benefits for the patient include
reduced travel times,9 reduced costs associated with
travelling, reduced waiting times and reduced impact
of travel on symptoms.10 They may feel more comfort-
able receiving their consultation in the comfort of their
own home.11 The reduction in travel provides an added
benefit to the environment by reducing the carbon
footprint.4,12 One study in Saudi Arabia looked at
how oncologists managed during the implementation
of virtual management of patients during the pandem-
ic.5 It showed that oncologists have a high level of
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awareness of virtual technology and 46% (n¼ 222) said
they definitely preferred managing some cases virtually
with only 36% saying they will continue virtual man-
agement after the pandemic.5
Of course, virtual care is not a new concept as many
NHS Trusts in the UK successfully use telephone clin-
ics13 not just in cancer. For example virtual clinics have
been shown to be successful in routine follow-up after
general surgery.14 This resulted in a reduction in unnec-
essary appointments allowing for more timely access
for newly referred patients.14 Video consulting has
also been successful within primary care.15 These exam-
ples are likely to have been driven by the NHS Long
Term Plan which recommends the uptake of digital
innovations to improve patient care and health
management.16
The purpose of this study was to determine the expe-
rience of cancer patients whose outpatient appoint-
ments changed from face-to-face to telephone during
the pandemic. Prior to the pandemic most of the out-
patient clinics were conducted in person with only a
few follow-up clinics taking place via the telephone.
Like so many other healthcare systems a new approach
was required at the start of the COVID-19 pandemic.
In a short period of time outpatient staff, medical,
clinical and haematology teams worked hard to make
the change to telephone consultations. A review of
the experience of patients is required to determine
whether this model would be sustainable going forward
and would help in the implementation of video
consultations.
Method
Purposive sampling was used to select the patient
sample. Initially a report was pulled from the electronic
patient record system. The criteria for this report was
patients who had a cancer diagnosis and had been
admitted for a day case in the last six months.
The report was exported to excel, and the author select-
ed patients who had had a telephone consultation since
23rd March. These patients were transferred to a
second list.
A telephone survey guide was prepared with a data
collection tool. Staff working in the four Macmillan
centres across the Trust were trained on how to use
both the guide and the data collection tool. The staff
called up patients by telephone on the second list
between 23rd June 2020 – 17th July 2020. The staff
divided up the list between them and called patients
until the selected sample size was reached and there
was a mix of patients with different cancers and from
different hospital sites. Eight questions were asked
using a mix of open and closed questions. The
requested sample size was 60 patients. This would
provide an initial insight to patient experience without
using excessive amounts of staff resourcing. The Trust
is made up of 4 main hospitals and 1 community site
with a variety of cancer services spread throughout. A
suggested sample of 60 was chosen as it was thought
that this would provide a suitable mix of patients with
different cancers who had had a telephone clinic from
the different sites. All patient data was anonymised.
Descriptive statistics was used to analyse the quan-
titative data. As the telephone surveys were not
recorded the qualitative data could not be analysed
verbatim, however common themes were drawn from
what the interviewers documented during their discus-
sions with the patients. As this study was deemed a
service evaluation ethics approval was not required.
Results
A total of 55 patients took part in a telephone survey.
The requested sample size was not reached as some
patients on the list were uncontactable, it was deemed
inappropriate to call them due to recent medical events
or on further investigation had not had a cancer tele-
phone clinic. At this point the main author determined
that there were sufficient data from a mix of patients
with different cancers who had had a telephone clinic
originating from one of more of the different hospital
sites and that data saturation was reached. The demo-
graphics of the patients are listed in Table 1.
The majority of telephone consultations were
described as follow-up consultations (Table 2). Most
consultations were conducted by doctors (43/55) but
some were conducted by nurses or conducted by both
nurse and doctor. Out of 55 patients, 39 patients rated
the telephone consultation they had as either 4 or 5 out
of 5 (1 – very dissatisfied and 5 – very satisfied). When
asked if they would like to continue with phone clinics
33 said they would, 18 said no, 1 patient was unsure
and 3 would like to alternate telephone with face-2-face
consultations.
Qualitative data capture was documented by the
staff undertaking the phone survey. This was either
documented as the patient was talking or written
down after the telephone call had taken placed. The
data was categorised into six themes (Table 3). The
fourth theme is split into two sub-themes.
Discussion
The pandemic of COVID-19 has been a difficult time
not only for patients17 with cancer and their families
but also staff working in cancer in NHS hospitals.18
It is essential when introducing new ways of
working that an evaluation is conducted.19 The pur-
pose of this study was to evaluate the wider
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implementation of telephone clinics within our cancer
services across the Trust.
This study provided a brief snapshot of the experi-
ence of patients who received a telephone consultation
instead of their usual face to face consultation during
the first wave of the pandemic. Many of the calls were
follow up calls. There were no consultations where bad
news was given. Rimmer20 explains the difficulties of
breaking bad news over the phone and provides advice.
It might be that none of the patients that were selected
through our purposive sampling were in a situation
where bad news had occurred or that our consulting
teams were still using face to face appointments for this
type of consultation. Follow up consultations do make
up a lot of the appointments normally therefore this
figure is in keeping with normal practice.
Most of the patients were reviewed by doctors
alone.21 It was unclear why some patients were seen
by both a nurse and a doctor. This could have been
due to patient complexity or due to a more MDT
approach to consultations in some tumour groups
compared to others.
As shown 39 patients rated the telephone consulta-
tion as either 4 or 5 out of 5 and 33 would like to
continue with them going forward. This is a very rudi-
mentary scoring system but it suggests that the major-
ity of our patients had a positive experience. Certainly,
from the qualitative data they were understanding of
the reasons as to why telephone clinics were intro-
duced. In a study by Beaver et al11 comparing hospital
and telephone follow-up after treatment for breast
cancer they found that those in the telephone group
reported greater satisfaction with the information
they received and found the support more helpful.
The qualitative data was characterised into six
themes (Table 3). Even though there were only three
patients who described the calls as rushed it was impor-
tant to note the impact and experience that these
patients would have had consequently. The telephone
consultations would have been new to a lot of staff and
therefore it would have taken a few consultations
before staff themselves felt comfortable.
The phrase ‘face to face’ was mentioned numerous
times and there clearly were some patients who pre-
ferred this option over the telephone option. Most of
the time it seemed to be more a personal preference
however there were examples where the patient felt
they needed to be physically seen and an anxious
patient who may have felt calmer seeing someone in
person. This leads onto the third theme whereby
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Table 3. Themes from the qualitative data with corresponding descriptions.
Theme Description
Rushed On the phone it felt rushed, as [the patient] could not discuss things at length.
The phone calls feel rushed, and [the patient] tended to forget important information due to this.
[The patient] felt rushed, lots of questions unanswered.
Face to face [The patient is] quite an anxious person and would prefer the face to face appointments.
[The patient] wanted face to face contact as she felt that her condition required eyes to see.
[The patient feels] much more comfortable when it is face to face.
Prefers in person. Telephone less personal.
Prefers face to face. Telephone useful if unwell.
[The patient] did miss face to face contact.
Difficult to assess [The patient] has found it hard due to her treatment side effects which are causing problems
in the hands and feet and she felt she could not explain these side effects well over the phone.
It was her first appointment after her surgery and she really needed the doctor to see the
breast surgery site. She did not know whether the healing was ok.
He would like someone to see his left ankle and see if the screw can be taken out and because
they couldn’t see it, it was hard to understand what to do next. They could not examine him
over the phone and he really hopes that face to face appointments are available soon.
[The patient] found it a real struggle and felt that he really needed to see someone so he can
talk face to face. The pain has been unmanageable and phone calls have not helped him too much.
Symptoms of recurrence are very difficult to assess over the phone, so the appointment was pointless.
Just needed to be examined by the doctor.
[The patient] would not want to miss out on a physical exam where necessary.
It is difficult to explain to the doctor the side effects and how the healing journey has been.
[The patient] feels very tender and cannot explain her symptoms very well so would prefer
to have someone feel and check.
Communication Positive communication Fully informative phone calls by the oncologist and Urology team.
[The patient] had a bleed and was very scared, she called her
consultant and was called back straight away and given a face
to face meeting the following week.
The doctor gave me time to understand. Clear information,
answered all my questions.
Very good - she spoke to my daughter as my English is not good.
[The patient] felt like it was easy to discuss anything over the phone.
[The patient] found the phone conversations quite hard . . . Not being
able to discuss her treatment plan at length is something
she found extremely difficult.
Barriers to communication [When the patient] has a face to face appointment, she was able to
get an interpreter whereas on the phone her son has had to translate.
She felt that even through translation she was unable to get her
side effects across to the doctor.
Was hard to understand at some times.
Benefits Saves time with virtual clinic. Finds coming up to hospital very stressful.
Saved travelling and sitting in waiting room for very short appointment.
Liked that she did not have to leave her house.
Less stress knowing I did not have to leave home.
No travel and no virus risk.
No travel or childcare needed
Compassionate care [The patient’s] CNS has been able to help him with any questions he has had and
supported him throughout.
[The patient’s] nurse has been very supportive, and attentive and also giving advice.
The phone calls picked her up when she has not been feeling great.
Consultant took time to explain. Answered all my questions, felt listened too.
Still felt friendly as has known consultant for long time.
The doctor was calming. Very thorough and the top of his game.
The doctor looked after me very well. The doctor was a good listener, felt he cared.
[The patient] knows that he can call his CNS whenever he needs . . . feel supported
in these difficult times.
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certain patients identified the issue with trying to
describe their condition where perhaps a physical
assessment was warranted. Having a set of inclusion
and exclusion criteria for telephone consultations
would be beneficial in this circumstance as then for
example the breast surgery patient would perhaps fall
into the exclusion criteria and would be automatically
contacted for a face to face appointment to review
wound care and healing.
There is a mix of opinions in terms of the overall
communication. Some patients described their tele-
phone conversation as very informative whereas
others had a harder time. One patient did not like the
fact that her son had to translate rather than the doctor
organising a translator. The patient felt this hindered
describing of their side effects. Another patient was
happy for their daughter to translate and speak to
the doctor. In these circumstances it may have been
useful to speak to the son and daughter to find what
their experience was. Reasons why a patient may have
found it difficult could be because they were hard of
hearing or the telephone line was not clear.
The majority of the patients saw the benefits of the
telephone consultations all of which complement the
literature described previously.9–11 These benefits are
likely to support the maintenance and sustainability
of virtual consultations going forward. The last
theme of compassionate care details comments where
staff made the patient feel at ease and gave them the
time they needed. These comments show that telephone
consultations can work successfully, and it is worth
evaluating and improving new services to ensure all
cancer patients receive the same experience as these
patients.
With a second wave now upon us it is likely that
telephone clinics will need to continue as an important
method for cancer care delivery.22 A small number of
our patients suggested the idea of alternating face to
face consultations with telephone consultations. This
has also been suggested by Parish et al.21 who reported
that this alternation would provide patients with more
scrutiny. This would benefit those patients who are
suffering with significant side effects.
As the pandemic of COVID-19 continues the
method in which cancer outpatient clinics are con-
ducted needs to be flexible and adaptable. As telephone
consultations have been implemented more widely,
video consultations have also started. Video consulta-
tions do require more technology9,23 than telephone
consultations but will offer added benefits.12,24,25 For
example video consultations may benefit our patient
suffering with palmar-plantar erythrodysesthesia as
she will be able to show her clinician the effects as
well as describe them.
This work has been fed back to the Trust cancer
directorate. A further service evaluation will be con-
ducted in the new year to include those patients who
have received a video consultation. It would also be
beneficial to interview clinicians to find what their
experience has been as well as any family members
who also took part in the consultations. A further
amendment to the method would be to record the tele-
phone survey to allow for verbatim transcription and
full thematic analysis. A limitation from this study that
will be present in the future study is that some patients
may be reluctant to be completely honest as the feed-
back method is not anonymous. This study provides
baseline data and learning which can be built on to
further improve our outpatient services to cancer
patients.
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